26 results
8-K
EX-10.1
INVA
Innoviva Inc
25 Aug 23
Innoviva Appoints Stephen Basso as Chief Financial Officer
5:24pm
time to time. Without limiting the foregoing, you agree that during your employment, you will devote your full business time, attention, skill and best
8-K
EX-99.1
INVA
Innoviva Inc
24 May 23
Corporate Presentation May 2023
5:18pm
management and board have world - class expertise in healthcare 15 Innoviva Team Superior capabilities and network Unique and complementary skill sets
8-K
EX-99.1
INVA
Innoviva Inc
14 Sep 22
Regulation FD Disclosure
5:22pm
in 2021 Superior capabilities and network Unique and complementary skill sets Strong value creation focus Proven track record of success Value
SC TO-C
EX-99.2
ETTX
Entasis Therapeutics Holdings Inc.
23 May 22
Information about tender offer
8:54pm
(Icahn Capital) Joined in 2021 World-class expertise Unique and complementary skill sets Strong value creation focus Proven track record of success
8-K
EX-10.1
INVA
Innoviva Inc
2 May 22
Departure of Directors or Certain Officers
5:27pm
. Without limiting the foregoing, you agree that during your employment, you will devote your full business time, attention, skill and best efforts
8-K
EX-99.1
2j5qqkfa47qa2gpoxm
7 Apr 22
Regulation FD Disclosure
5:09pm
8-K
EX-4.1
g301t7 xto
8 Mar 22
Innoviva Announces Proposed Offering of $200 Million of Convertible Senior Notes
5:15pm
8-K
EX-99.1
ltu564w5
13 Dec 21
Corporate Presentation December 2021
4:39pm
8-K
EX-10.1
z2g fqopzk
12 Jun 20
Departure of Directors or Certain Officers
4:42pm
8-K
EX-10.1
cxcorng ho
26 May 20
Departure of Directors or Certain Officers
5:14pm
8-K
EX-10.2
ik9orax
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-4.4
zgrzt57i
25 Jan 13
Theravance Announces Closing of Public Offering of $287.5 Million of Convertible Subordinated Notes
12:00am
S-3ASR
EX-4.4
ip9xnq
16 Jan 13
Automatic shelf registration
12:00am
424B5
8k4fipz2mzlhgy
19 Mar 10
Prospectus supplement for primary offering
12:00am
424B5
o3h4yljdzyld8yny
17 Mar 10
Prospectus supplement for primary offering
12:00am
S-3
4e2fuxvapm
23 Jul 09
Shelf registration
12:00am